Event
Feb 26, 2026
Bioscibex will officially unveil its flagship bioreactor, SW1NGO, at ESACT 2026 in Salzburg, Austria. The conference will mark the system’s first public showcase, featuring live demonstrations ahead of its planned commercial rollout later that year.
Bioscibex will officially unveil its flagship single-use bioreactor-incubator, SW1NGO, at the ESACT 2026 conference in Salzburg, Austria. This event marks the first time the innovative system will be showcased to the public, offering a unique opportunity for biopharmaceutical professionals to see the technology in action.
The ESACT (European Society for Animal Cell Technology) is one of the leading global conferences for cell culture and bioprocessing professionals. ESACT gathers scientists, engineers, and industry leaders to share breakthroughs in cell culture technologies, biomanufacturing processes, and innovative applications in biopharma. Presenting SW1NGO at ESACT positions Bioscibex at the forefront of cutting-edge biomanufacturing innovation.
Attendees at ESACT 2026 will have the chance to see live demonstrations of SW1NGO, explore its scalable single-use design, and discuss potential applications with the Bioscibex team. The launch underscores Bioscibex’s mission to transform biomanufacturing and marks a key milestone on the path to its commercial rollout in 2026.
